This is the authors' abstract. We don't add key points for this paper.
In a previous study, a cocrystal structure of PPARγ bound to 2-chloro- N -(3-chloro-4-((5-chlorobenzo[ d ]thiazol-2-yl)thio)phenyl)-4-(trifluoromethyl)benzenesulfonamide ( 1, T2384) revealed two orthosteric pocket binding modes attributed to a concentration-dependent biochemical activity profile. However, 1 also bound an alternate/allosteric site that could alternatively account for the profile. Here, we show ligand aggregation afflicts the activity profile of 1 in biochemical assays. However, ligand-observed fluorine ( 19 F) and protein-observed NMR confirms 1 binds PPARγ with two orthosteric binding modes and to an allosteric site.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: